Biotech Updates

Ex-ante Analysis of Biotech Papaya in Thailand

October 16, 2009

Total economic surplus ranging from $650 million to $1.5 billion USD would be generated within the first 10 years of adoption if Thailand were to authorize the use of genetically modified (GM) technology. These benefits would accrue primarily to small-scale papaya farmers and be realized even with the loss of export markets. These are highlights of an article Ex-ante Impact Assessment of GM Papaya Adoption in Thailand by Orachos Napasintuwong of Kasetsart University and Greg Traxler of Auburn University, USA.

Thailand's concern over the loss of export markets and health and environmental risks, according to the authors, have led to uncertainty and indecision about policies to support biotechnology in the country.

View the full report and other articles in the e-journal AgbioForum at